Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor

Journal of Virology

Volumn 89, Issue 5, 2015, Pages 2684-2697

  Kanda, Teru ^a   Miyata, Mamiko ^a   Kano, Makoto ^b   Kondo, Satoru ^b   Yoshizaki, Tomokazu ^b   Iizasa, Hisashi ^c  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PROTEIN NDRG1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; N-MYC DOWNSTREAM-REGULATED GENE 1 PROTEIN; SIGNAL PEPTIDE; VIRUS DNA; VIRUS RNA;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL SPECIFICITY; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NASOPHARYNX CARCINOMA; NDRG1 GENE; NONHUMAN; PROTEIN EXPRESSION; VIRUS CARCINOGENESIS; VIRUS STRAIN; ANTAGONISTS AND INHIBITORS; GENE EXPRESSION PROFILING; GENE LOCUS; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOHISTOCHEMISTRY; METABOLISM; METASTASIS; MICROARRAY ANALYSIS; NASOPHARYNX TUMOR; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

BACTERIA (MICROORGANISMS); HUMAN HERPESVIRUS 4;

CELL CYCLE PROTEINS; DNA, VIRAL; DOWN-REGULATION; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GENETIC LOCI; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROARRAY ANALYSIS; MICRORNAS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; RNA, VIRAL;

EID: 84922962814     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03189-14     Document Type: Article

References (65)

1. Rickinson AB, Kieff E. 2007. Epstein-Barr virus, p 2603-2654. In Knipe DM, Howley PM (ed), Fields virology, 5th ed. Lippincott/The Williams & Wilkins Co, Philadelphia, PA.
2. Miller G, Lipman M. 1973. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 70:190-194. http://dx.doi.org/10.1073/pnas.70.1.190.
3. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211. http://dx.doi.org/10.1038/310207a0.
4. Raab-Traub N, Dambaugh T, Kieff E. 1980. DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative. Cell 22:257-267. http://dx.doi.org/10.1016/0092-8674(80)90173-7.
5. Skare J, Edson C, Farley J, Strominger JL. 1982. The B95-8 isolate of Epstein-Barr virus arose from an isolate with a standard genome. J Virol 44:1088-1091.
6. Cai X, Schafer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, Raab-Traub N, Cullen BR. 2006. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2:e23. http://dx.doi.org/10.1371/journal.ppat.0020023.
7. Grundhoff A, Sullivan CS, Ganem D. 2006. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gammaherpesviruses. RNA 12:733-750. http://dx.doi.org/10.1261/rna.2326106.
8. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T. 2004. Identification of virusencoded microRNAs. Science 304:734-736. http://dx.doi.org/10.1126/science.1096781.
9. Zhu JY, Pfuhl T, Motsch N, Barth S, Nicholls J, Grasser F, Meister G. 2009. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol 83:3333-3341. http://dx.doi.org/10.1128/JVI.01689-08.
10. Hitt MM, Allday MJ, Hara T, Karran L, Jones MD, Busson P, Tursz T, Ernberg I, Griffin BE. 1989. EBV gene expression in an NPC-related tumour. EMBO J 8:2639-2651.
11. Gilligan KJ, Rajadurai P, Lin JC, Busson P, Abdel-Hamid M, Prasad U, Tursz T, Raab-Traub N. 1991. Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J Virol 65:6252-6259.
12. Sadler RH, Raab-Traub N. 1995. Structural analyses of the Epstein-Barr virus BamHI A transcripts. J Virol 69:1132-1141.
13. Smith PR, de Jesus O, Turner D, Hollyoake M, Karstegl CE, Griffin BE, Karran L, Wang Y, Hayward SD, Farrell PJ. 2000. Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus. J Virol 74: 3082-3092. http://dx.doi.org/10.1128/JVI.74.7.3082-3092.2000.
14. Edwards RH, Marquitz AR, Raab-Traub N. 2008. Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J Virol 82:9094-9106. http://dx.doi.org/10.1128/JVI.00785-08.
15. Cosmopoulos K, Pegtel M, Hawkins J, Moffett H, Novina C, Middeldorp J, Thorley-Lawson DA. 2009. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J Virol 83:2357-2367. http://dx.doi.org/10.1128/JVI.02104-08.
16. Kim do N, Chae HS, Oh ST, Kang JH, Park CH, Park WS, Takada K, Lee JM, Lee WK, Lee SK. 2007. Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol 81:1033-1036. http://dx.doi.org/10.1128/JVI.02271-06.
17. Ramakrishnan R, Donahue H, Garcia D, Tan J, Shimizu N, Rice AP, Ling PD. 2011. Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasalNKT cell lymphomas. PLoS One 6:e27271. http://dx.doi.org/10.1371/journal.pone.0027271.
18. Lo AK, Dawson CW, Jin DY, Lo KW. 2012. The pathological roles of BART miRNAs in nasopharyngeal carcinoma. J Pathol 227:392-403. http://dx.doi.org/10.1002/path.4025.
19. Marquitz AR, Raab-Traub N. 2012. The role of miRNAs and EBV BARTs in NPC. Semin Cancer Biol 22:166-172. http://dx.doi.org/10.1016/j.semcancer.2011.12.001.
20. Raab-Traub N. 2012. Novel mechanisms of EBV-induced oncogenesis. Curr Opin Virol 2:453-458. http://dx.doi.org/10.1016/j.coviro.2012.07.001.
21. Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, Kremmer E, Jaker C, Hock J, Meister G, Grasser FA. 2008. Epstein-Barr virus-encoded microRNA miR-BART2 downregulates the viralDNApolymerase BALF5. Nucleic Acids Res 36:666-675.
22. Lo AK, To KF, Lo KW, Lung RW, Hui JW, Liao G, Hayward SD. 2007. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci USA 104:16164-16169. http://dx.doi.org/10.1073/pnas.0702896104.
23. Lung RW, Tong JH, Sung YM, Leung PS, Ng DC, Chau SL, Chan AW, Ng EK, Lo KW, To KF. 2009. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia 11:1174-1184.
24. Riley KJ, Rabinowitz GS, Yario TA, Luna JM, Darnell RB, Steitz JA. 2012. EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J 31:2207-2221. http://dx.doi.org/10.1038/emboj.2012.63.
25. Marquitz AR, Mathur A, Nam CS, Raab-Traub N. 2011. The Epstein-Barr Virus BART microRNAs target the proapoptotic protein Bim. Virology 412:392-400. http://dx.doi.org/10.1016/j.virol.2011.01.028.
26. Vereide DT, Seto E, Chiu YF, Hayes M, Tagawa T, Grundhoff A, Hammerschmidt W, Sugden B. 2014. Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene 33:1258-1264. http://dx.doi.org/10.1038/onc.2013.71.
27. Skalsky RL, Corcoran DL, Gottwein E, Frank CL, Kang D, Hafner M, Nusbaum JD, Feederle R, Delecluse HJ, Luftig MA, Tuschl T, Ohler U, Cullen BR. 2012. The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog 8:e1002484. http://dx.doi.org/10.1371/journal.ppat.1002484.
28. Iizasa H, Wulff BE, Alla NR, Maragkakis M, Megraw M, Hatzigeorgiou A, Iwakiri D, Takada K, Wiedmer A, Showe L, Lieberman P, Nishikura K. 2010. Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. J Biol Chem 285:33358-33370. http://dx.doi.org/10.1074/jbc.M110.138362.
29. Hsu CY, Yi YH, Chang KP, Chang YS, Chen SJ, Chen HC. 2014. The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma. PLoS Pathog 10:e1003974. http://dx.doi.org/10.1371/journal.ppat.1003974.
30. Dolken L, Malterer G, Erhard F, Kothe S, Friedel CC, Suffert G, Marcinowski L, Motsch N, Barth S, Beitzinger M, Lieber D, Bailer SM, Hoffmann R, Ruzsics Z, Kremmer E, Pfeffer S, Zimmer R, Koszinowski UH, Grasser F, Meister G, Haas J. 2010. Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gammaherpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 7:324-334. http://dx.doi.org/10.1016/j.chom.2010.03.008.
31. Choy EY, Siu KL, Kok KH, Lung RW, Tsang CM, To KF, Kwong DL, Tsao SW, Jin DY. 2008. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 205:2551-2560. http://dx.doi.org/10.1084/jem.20072581.
32. Gottwein E, Corcoran DL, Mukherjee N, Skalsky RL, Hafner M, Nusbaum JD, Shamulailatpam P, Love CL, Dave SS, Tuschl T, Ohler U, Cullen BR. 2011. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10:515-526. http://dx.doi.org/10.1016/j.chom.2011.09.012.
33. Feederle R, Bartlett EJ, Delecluse HJ. 2010. Epstein-Barr virus genetics: talking about the BAC generation. Herpesviridae 1:6. http://dx.doi.org/10.1186/2042-4280-1-6.
34. Shaw G, Morse S, Ararat M, Graham FL. 2002. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 16:869-871. http://dx.doi.org/10.1096/fj.01-0995fje.
35. Delecluse HJ, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W. 1998. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci USA 95:8245-8250. http://dx.doi.org/10.1073/pnas.95.14.8245.
36. Takada K, Horinouchi K, Ono Y, Aya T, Osato T, Takahashi M, Hayasaka S. 1991. An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5:147-156. http://dx.doi.org/10.1007/BF00571929.
37. Strong MJ, Baddoo M, Nanbo A, Xu M, Puetter A, Lin Z. 2014. Comprehensive RNA-seq analysis reveals contamination of multiple nasopharyngeal carcinoma cell lines with HeLa cell genomes. J Virol 88: 10696-10704. http://dx.doi.org/10.1128/JVI.01457-14.
38. Takimoto T, Sato H, Ogura H, Miyawaki T, Glaser R. 1986. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor. Cancer Res 46:2541-2544.
39. Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whitney BM, Lee JC. 1999. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer 83:121-126. http://dx.doi.org/10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F.
40. Kanda T, Shibata S, Saito S, Murata T, Isomura H, Yoshiyama H, Takada K, Tsurumi T. 2011. Unexpected instability of family of repeats (FR), the critical cis-acting sequence required for EBV latent infection, in EBV-BAC systems. PLoS One 6:e27758. http://dx.doi.org/10.1371/journal.pone.0027758.
41. Kanda T, Yajima M, Ahsan N, Tanaka M, Takada K. 2004. Production of high-titer Epstein-Barr virus recombinants derived from Akata cells by using a bacterial artificial chromosome system. J Virol 78:7004-7015. http://dx.doi.org/10.1128/JVI.78.13.7004-7015.2004.
42. Nakano Y, Yoshida Y, Yamashita Y, Koga T. 1995. Construction of a series of pACYC-derived plasmid vectors. Gene 162:157-158. http://dx.doi.org/10.1016/0378-1119(95)00320-6.
43. Fruscalzo A, Marsili G, Busiello V, Bertolini L, Frezza D. 2001. DNA sequence heterogeneity within the Epstein-Barr virus family of repeats in the latent origin of replication. Gene 265:165-173. http://dx.doi.org/10.1016/S0378-1119(01)00345-6.
44. Kanda T, Horikoshi N, Murata T, Kawashima D, Sugimoto A, Narita Y, Kurumizaka H, Tsurumi T. 2013. Interaction between basic residues of Epstein-Barr virus EBNA1 protein and cellular chromatin mediates viral plasmid maintenance. J Biol Chem 288:24189-24199. http://dx.doi.org/10.1074/jbc.M113.491167.
45. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ. 2005. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33:e179. http://dx.doi.org/10.1093/nar/gni178.
46. Shimada A, Dohke K, Sadaie M, Shinmyozu K, Nakayama J, Urano T, Murakami Y. 2009. Phosphorylation of Swi6/HP1 regulates transcriptional gene silencing at heterochromatin. Genes Dev 23:18-23. http://dx.doi.org/10.1101/gad.1708009.
47. Kitagawa N, Kondo S, Wakisaka N, Zen Y, Nakanishi Y, Tsuji A, Endo K, Murono S, Yoshizaki T. 2013. Expression of seven-in-absentia homologue 1 and hypoxia-inducible factor 1 alpha: novel prognostic factors of nasopharyngeal carcinoma. Cancer Lett 331:52-57. http://dx.doi.org/10.1016/j.canlet.2012.12.002.
48. de Jesus O, Smith PR, Spender LC, Elgueta Karstegl C, Niller HH, Huang D, Farrell PJ. 2003. Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J Gen Virol 84:1443-1450. http://dx.doi.org/10.1099/vir.0.19054-0.
49. Bloss TA, Sugden B. 1994. Optimal lengths for DNAs encapsidated by Epstein-Barr virus. J Virol 68:8217-8222.
50. Qiu J, Cosmopoulos K, Pegtel M, Hopmans E, Murray P, Middeldorp J, Shapiro M, Thorley-Lawson DA. 2011. A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog 7:e1002193. http://dx.doi.org/10.1371/journal.ppat.1002193.
51. Paraskevopoulou MD, Georgakilas G, Kostoulas N, Vlachos IS, Vergoulis T, Reczko M, Filippidis C, Dalamagas T, Hatzigeorgiou AG. 2013. DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Res 41:W169-W173. http://dx.doi.org/10.1093/nar/gkt393.
52. Lachat P, Shaw P, Gebhard S, van Belzen N, Chaubert P, Bosman FT. 2002. Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol 118:399-408. http://dx.doi.org/10.1007/s00418-002-0460-9.
53. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233. http://dx.doi.org/10.1016/j.cell.2009.01.002.
54. Marquitz AR, Mathur A, Chugh PE, Dittmer DP, Raab-Traub N. 2014. Expression Profile of MicroRNAs in Epstein-Barr Virus-Infected AGS Gastric Carcinoma Cells. J Virol 88:1389-1393. http://dx.doi.org/10.1128/JVI.02662-13.
55. Klinke O, Feederle R, Delecluse HJ. 2014. Genetics of Epstein-Barr virus microRNAs. Semin Cancer Biol 26:52-59. http://dx.doi.org/10.1016/j.semcancer.2014.02.002.
56. Seto E, Moosmann A, Gromminger S, Walz N, Grundhoff A, Hammerschmidt W. 2010. Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog 6:e1001063. http://dx.doi.org/10.1371/journal.ppat.1001063.
57. Chen H, Huang J, Wu FY, Liao G, Hutt-Fletcher L, Hayward SD. 2005. Regulation of expression of the Epstein-Barr virus BamHI-A rightward transcripts. J Virol 79:1724-1733. http://dx.doi.org/10.1128/JVI.79.3.1724-1733.2005.
58. Walz N, Christalla T, Tessmer U, Grundhoff A. 2010. A global analysis of evolutionary conservation among known and predicted gammaherpesvirus microRNAs. J Virol 84:716-728. http://dx.doi.org/10.1128/JVI.01302-09.
59. Hurst DR, Edmonds MD, Welch DR. 2009. Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res 69:7495-7498. http://dx.doi.org/10.1158/0008-5472.CAN-09-2111.
60. Ellen TP, Ke Q, Zhang P, Costa M. 2008. NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis 29:2-8.
61. Kovacevic Z, Richardson DR. 2006. The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer. Carcinogenesis 27:2355-2366. http://dx.doi.org/10.1093/carcin/bgl146.
62. Liu W, Xing F, Iiizumi-Gairani M, Okuda H, Watabe M, Pai SK, Pandey PR, Hirota S, Kobayashi A, Mo YY, Fukuda K, Li Y, Watabe K. 2012. N-myc downstream regulated gene 1 modulates Wnt-beta-catenin signaling and pleiotropically suppresses metastasis. EMBO Mol Med 4:93-108. http://dx.doi.org/10.1002/emmm.201100190.
63. White BD, Chien AJ, Dawson DW. 2012. Dysregulation of Wnt/betacatenin signaling in gastrointestinal cancers. Gastroenterology 142:219-232. http://dx.doi.org/10.1053/j.gastro.2011.12.001.
64. Kuzembayeva M, Hayes M, Sugden B. 2014. Multiple functions are mediated by the miRNAs of Epstein-Barr virus. Curr Opin Virol 7:61-65. http://dx.doi.org/10.1016/j.coviro.2014.04.003.
65. Dawson CW, Eliopoulos AG, Blake SM, Barker R, Young LS. 2000. Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1and a nasopharyngeal carcinoma-derivedLMP1in human epithelial cells. Virology 272:204-217. http://dx.doi.org/10.1006/viro.2000.0344.